NCT05083299View on ClinicalTrials.gov

Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate

CompletedOBSERVATIONAL
Enrollment

1,003

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions
Chronic Occlusive Arterial Disease
Interventions
DRUG

Sarpogrelate

Anpl-one SR

Trial Locations (1)

49267

BuKyung Kim, Busan

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY